EW
Edwards Lifesciences Corp
NYSE: EW · HEALTHCARE · MEDICAL DEVICES
$81.22
-1.29% today
Updated 2026-04-29
Market cap
$46.83B
P/E ratio
43.90
P/S ratio
7.43x
EPS (TTM)
$1.85
Dividend yield
—
52W range
$72 – $88
Volume
5.0M
Edwards Lifesciences Corp (EW) Financial statements
SEC filings — annual and quarterly data.
Profit margin
17.40%
Operating margin
31.20%
ROE
10.30%
ROA
7.65%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $1.04B | $130.50M | 63.04% | 15.77% | 12.58% |
| 2007 | $1.09B | $113.00M | 65.05% | 15.53% | 10.36% |
| 2008 | $1.24B | $128.90M | 66.96% | 16.89% | 10.41% |
| 2009 | $1.32B | $229.10M | 69.80% | 18.01% | 17.34% |
| 2010 | $1.45B | $218.00M | 71.66% | 19.52% | 15.07% |
| 2011 | $1.68B | $236.70M | 72.55% | 19.61% | 14.10% |
| 2012 | $1.90B | $293.20M | 73.32% | 20.88% | 15.43% |
| 2013 | $2.05B | $391.70M | 73.41% | 21.17% | 19.15% |
| 2014 | $2.32B | $811.10M | 72.83% | 20.97% | 34.92% |
| 2015 | $2.49B | $494.90M | 72.56% | 23.09% | 19.85% |
| 2016 | $2.96B | $569.50M | 72.81% | 27.52% | 19.22% |
| 2017 | $3.44B | $622.10M | 74.30% | 29.40% | 18.11% |
| 2018 | $3.72B | $722.20M | 75.23% | 29.34% | 19.40% |
| 2019 | $4.35B | $1.05B | 73.43% | 27.55% | 24.08% |
| 2020 | $4.39B | $823.40M | 74.94% | 29.55% | 18.77% |
| 2021 | $5.23B | $1.50B | 76.57% | 30.78% | 28.73% |
| 2022 | $5.38B | $1.52B | 78.31% | 31.63% | 28.28% |
| 2023 | $6.00B | $1.40B | 77.02% | 25.55% | 23.35% |
| 2024 | $5.44B | $4.17B | 79.46% | 25.35% | 76.75% |
| 2025 | $6.07B | $1.07B | 78.13% | 26.97% | 17.69% |